These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 10969684

  • 1. Neutrophil degranulation and complement activation during fetal cardiac bypass.
    Parry AJ, Petrossian E, McElhinney DB, Reddy VM, Hanley FL.
    Ann Thorac Surg; 2000 Aug; 70(2):582-9. PubMed ID: 10969684
    [Abstract] [Full Text] [Related]

  • 2. Fetal cardiac bypass using an in-line axial flow pump to minimize extracorporeal surface and avoid priming volume.
    Reddy VM, Liddicoat JR, Klein JR, McElhinney DB, Wampler RK, Hanley FL.
    Ann Thorac Surg; 1996 Aug; 62(2):393-400. PubMed ID: 8694597
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandin synthesis inhibition prevents placental dysfunction after fetal cardiac bypass.
    Sabik JF, Assad RS, Hanley FL.
    J Thorac Cardiovasc Surg; 1992 Apr; 103(4):733-41; discussion 741-2. PubMed ID: 1548915
    [Abstract] [Full Text] [Related]

  • 4. Pulsatility improves hemodynamics during fetal bypass. Experimental comparative study of pulsatile versus steady flow.
    Champsaur G, Parisot P, Martinot S, Ninet J, Robin J, Ovize M, Brulé P, Neidecker J, Franck M.
    Circulation; 1994 Nov; 90(5 Pt 2):II47-50. PubMed ID: 7955281
    [Abstract] [Full Text] [Related]

  • 5. Fetal cardiac intervention: improved results of fetal cardiac bypass in immature fetuses using the TinyPump device.
    Sebastian VA, Ferro G, Kagawa H, Nasirov T, Maeda K, Ferrier WT, Takatani S, Riemer RK, Hanley FL, Reddy VM.
    J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1460-4. PubMed ID: 22944083
    [Abstract] [Full Text] [Related]

  • 6. Role of the endothelium in placental dysfunction after fetal cardiac bypass.
    Reddy VM, McElhinney DB, Rajasinghe HA, Liddicoat JR, Hendricks-Munoz K, Fineman JR, Hanley FL.
    J Thorac Cardiovasc Surg; 1999 Feb; 117(2):343-51. PubMed ID: 9918976
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome after fetal cardiac bypass: fetal survival to full term and organ abnormalities.
    Reddy VM, Liddicoat JR, Klein JR, Wampler RK, Hanley FL.
    J Thorac Cardiovasc Surg; 1996 Mar; 111(3):536-44. PubMed ID: 8601967
    [Abstract] [Full Text] [Related]

  • 8. Neutrophil lactoferrin release during open heart surgery is unrelated to complement activation.
    Shastri KA, Logue GL, Stern MP, Raza S, O'Connor BM, Bovill JJ, Hoover EL.
    ASAIO J; 1994 Mar; 40(1):56-61. PubMed ID: 8186493
    [Abstract] [Full Text] [Related]

  • 9. Activation of neutrophil granulocytes in an in vitro model of a cardiopulmonary bypass.
    Asberg AE, Videm V.
    Artif Organs; 2005 Dec; 29(12):927-36. PubMed ID: 16305648
    [Abstract] [Full Text] [Related]

  • 10. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation.
    Böhler J, Schollmeyer P, Dressel B, Dobos G, Hörl WH.
    J Am Soc Nephrol; 1996 Feb; 7(2):234-41. PubMed ID: 8785392
    [Abstract] [Full Text] [Related]

  • 11. Preliminary results of fetal cardiac bypass in nonhuman primates.
    Ikai A, Riemer RK, Ramamoorthy C, Malhotra S, Cassorla L, Amir G, Hanley FL, Reddy VM.
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):175-81. PubMed ID: 15632840
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of nitric oxide pathway in placental dysfunction following fetal bypass.
    Lam C, Baker RS, McNamara J, Ferguson R, Lombardi J, Clark K, Eghtesady P.
    Ann Thorac Surg; 2007 Sep; 84(3):917-24; discussion 924-5. PubMed ID: 17720400
    [Abstract] [Full Text] [Related]

  • 14. Vacuum-assisted venous drainage during fetal cardiopulmonary bypass.
    Lubbers WC, Baker RS, Sedgwick JA, Lam CT, Schenbeck JL, McNamara JL, Ferguson RE, Lombardi J, Gardner A, Clark KE, Eghtesady P.
    ASAIO J; 2005 Sep; 51(5):644-8. PubMed ID: 16322731
    [Abstract] [Full Text] [Related]

  • 15. Cytokine Response to Fetal Cardiac Bypass.
    Reddy VM, McElhinney DB, Rajasinghe HA, Rodriguez JL, Hanley FL.
    J Matern Fetal Investig; 1998 Mar; 8(1):46-9. PubMed ID: 9524160
    [Abstract] [Full Text] [Related]

  • 16. Fetal cardiac bypass alters regional blood flows, arterial blood gases, and hemodynamics in sheep.
    Bradley SM, Hanley FL, Duncan BW, Jennings RW, Jester JA, Harrison MR, Verrier ED.
    Am J Physiol; 1992 Sep; 263(3 Pt 2):H919-28. PubMed ID: 1415619
    [Abstract] [Full Text] [Related]

  • 17. Better preservation of endothelial function and decreased activation of the fetal renin-angiotensin pathway with the use of pulsatile flow during experimental fetal bypass.
    Vedrinne C, Tronc F, Martinot S, Robin J, Allevard AM, Vincent M, Lehot JJ, Franck M, Champsaur G.
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):770-7. PubMed ID: 11003761
    [Abstract] [Full Text] [Related]

  • 18. A simple solution is "prime" for fetal cardiopulmonary bypass.
    Baker RS, Lam CT, Heeb EA, Hilshorst JL, Ferguson R, Lombardi J, Eghtesady P.
    ASAIO J; 2007 Oct; 53(6):710-5. PubMed ID: 18043153
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-dose steroids prevent placental dysfunction after fetal cardiac bypass.
    Sabik JF, Heinemann MK, Assad RS, Hanley FL.
    J Thorac Cardiovasc Surg; 1994 Jan; 107(1):116-24; discussion 124-5. PubMed ID: 8283873
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.